+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States



Economic impact of severe and non-severe hypoglycemia in patients with Type 1 and Type 2 diabetes in the United States



Journal of Medical Economics 18(6): 420-432



To identify the direct and indirect costs of hypoglycemia in patients with Type 1 or Type 2 diabetes mellitus (DM) in the US setting. A literature review was conducted to identify and review studies that reported data on the economic burden of hypoglycemia and the related medical resource consumption or productivity loss related to hypoglycemia in patients with Type 1 or Type 2 DM. Relevant information was collated in an economic model to assess the direct and indirect costs following severe and non-severe hypoglycemic events in Type 1 and Type 2 DM. Detailed evidence of the medical cost burden of hypoglycemic events was identified from 14 studies. For both Type 1 and Type 2 DM, episodes requiring assistance from a healthcare practitioner were identified as particularly costly and amounted to $1161 per episode (direct costs) compared with episode costs of $66 and $11 for events requiring third-party (non-medical) assistance and events managed by self-treatment, respectively. Indirect costs associated with severe hypoglycemia requiring non-medical assistance, severe hypoglycemia requiring medical assistance, and non-severe hypoglycemia were predicted to be $242, $160, and $11 for patients with Type 1 diabetes and $579, $176, and $11 for patients with Type 2 diabetes, respectively. Both severe and non-severe hypoglycemia incur substantial healthcare costs. Failure to account for these costs may under-estimate the value of management strategies that minimize hypoglycemia risk.

(PDF emailed within 0-6 h: $19.90)

Accession: 057685911

Download citation: RISBibTeXText

PMID: 25629654

DOI: 10.3111/13696998.2015.1006730


Related references

The impact of severe hypoglycemia and impaired awareness of hypoglycemia on relatives of patients with type 1 diabetes. Diabetes Care 26(4): 1106-1109, 2003

Treating diabetes to accepted standards of care: a 10-year projection of the estimated economic and health impact in patients with type 1 and type 2 diabetes mellitus in the United States. Clinical Therapeutics 27(6): 940-950, 2005

The impact of non-severe hypoglycemia on quality of life in patients with type 2 diabetes. Journal of Diabetes and Its Complications, 2018

Hypoglycemia Awareness and Severe Hypoglycemia in the Global HAT Study of 27,585 Patients With Type 1 (T1D) and Type 2 Diabetes (T2D). Canadian Journal of Diabetes 41(5): S26-S27, 2017

Impact of genetic polymorphism in the b-receptor gene on risk of severe hypoglycemia in patients with type 1 diabetes. Journal of Clinical Endocrinology and Metabolism, 2018

Quantifying the Trade-off Between Improved Glycemic Control and Severe Hypoglycemia Risk in Patients with Type 1 Diabetes: A Health Economic Analysis in the Uk. Value in Health 20(9): A486-A487, 2017

Sustained efficacy of continuous subcutaneous insulin infusion in type 1 diabetes subjects with recurrent non-severe and severe hypoglycemia and hypoglycemia unawareness: a pilot study. Diabetes Technology & Therapeutics 12(7): 517-521, 2010

Insulin lispro lowers the incidence of severe hypoglycemia, without a detrimental effect on glycemic control, in those individuals with type 1 diabetes at high risk of severe hypoglycemia. Diabetes 48(SUPPL 1): A122, 1999

Accumulation of severe hypoglycemia at weekends and in warm seasons in patients with type 1 diabetes but not with type 2 diabetes. Journal of Diabetes and Its Complications 30(7): 1308-1314, 2016

Seasonal variations of severe hypoglycemia in patients with type 1 diabetes mellitus, type 2 diabetes mellitus, and non-diabetes mellitus: clinical analysis of 578 hypoglycemia cases. Medicine 93(23): E148-E148, 2015

Hormonal counterregulation during severe hypoglycemia in patients with Type 1-versus Type 2-diabetes. Diabetes & Metabolism 29(Hors serie 2): 4S239, August, 2003

Effect of Insulin Analogs on Frequency of Non-Severe Hypoglycemia in Patients with Type 1 Diabetes Prone to Severe Hypoglycemia: Much Higher Rates Detected by Continuous Glucose Monitoring than by Self-Monitoring of Blood Glucose-The HypoAna Trial. Diabetes Technology & Therapeutics 20(3): 247-256, 2018

Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia. Diabetes Care. 17(7): 697-703, 1994

The impact of severe hypoglycemia on renal impairment in type 2 diabetes. Diabetes Research and Clinical Practice 108(3): 448-455, 2016

Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care 36(12): 4160-4162, 2014